Abstract:Background: Cardiac injury is recognized as one of the most common critical complications during exacerbation of coronavirus disease 2019 (COVID-19). This study aimed to investigate the effect of cardiac injury on the clinical course of COVID-19 and to examine its potential mechanism and treatments.Methods and Results: A total of 222 hospitalized patients with COVID-19 from Wuhan were selected for the study during February 10 to March 28, 2020. Demographic, laboratory, and clinical data on admission and during hospitalization were compared between patients with COVID-19 with or without cardiac injury. On admission, cardiac injury (n = 29) was associated with advanced age, more underlying coronary artery disease, and a lower PaO2. Troponin levels were correlated with inflammatory markers (C-reactive protein: r = 0.348, P < 0.001; interleukin 6: r = 0.558, P < 0.001) and D-dimer levels (r = 0.598, P < 0.001). During hospitalization, another six patients suffered from cardiac injury and cardiac injury (n = 35), resulting in higher rates of ventilation (invasive: 51.4 vs. 1.6%, P < 0.001; non-invasive: 31.4 vs. 1.1%, P < 0.001) and mortality (54.3 vs. 1.1%, P < 0.001). Cardiac injury on admission was a predictive factor for mortality (adjusted hazard ratio = 4.73, 95% confidence interval = 1.35–16.63, P = 0.015). Receiver operating characteristic curve analysis showed that, on admission, a troponin level of 36.35 pg/mL was predictive for mortality with a sensitivity of 73.7% and a specificity of 92.1%.Conclusions: Cardiac injury complicates the disease course and increases the mortality rate of COVID-19. Troponin levels should be checked at admission and during hospitalization for triage, better monitoring, and managing those with COVID-19, especially in the most severe patients.Condensed Cardiac injury is not uncommon in COVID-19. In a cohort of 222 patients with COVID-19, cardiac injury was found in 29 patients on admission and in another 6 patients during hospitalization. The admission level of troponin was well-correlated with inflammatory factors and D-dimer levels and strongly predicted mortality. Cardiac injury is a manifestation secondary to hypoxia and systemic infection, but which nevertheless further complicates the disease course and increases the mortality rate. Troponin levels should be checked at admission and during hospitalization for triage, better monitoring, and managing those with COVID-19, especially in the most severe patients.

Transient Cardiac Injury During H7N9 Infection

Laboratory findings in patients with avian-origin influenza A (H7N9) virus infections.

Cardiac Injury In Patients With Pandemic 2009 Influenza A (H1n1) Infection

Immune derangement occurs in patients with H7N9 avian influenza

Muscle Weakness Associated with H7N9 Infection: Report of Two Cases

Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus.

Angiotensin II Plasma Levels Are Linked to Disease Severity and Predict Fatal Outcomes in H7N9-infected Patients.

Clinical findings in 111 cases of influenza A (H7N9) virus infection.

Severe Infection with Avian Influenza A Virus is Associated with Delayed Immune Recovery in Survivors

An analysis of clinical characteristics of human infection with H7N9 avian influenza complicated by acute respiratory distress syndrome

Long term outcomes in survivors of epidemic Influenza A (H7N9) virus infection

Novel Pathogenic Characteristics of Highly Pathogenic Avian Influenza Virus H7N9: Viraemia and Extrapulmonary Infection

Clinical Characteristics of 26 Human Cases of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in China.

The Serum Profile of Hypercytokinemia Factors Identified in H7n9-Infected Patients Can Predict Fatal Outcomes

A New Perspective on C-Reactive Protein in H7n9 Infections

Severe H7N9 Infection is Associated with Decreased Antigen-Presenting Capacity of CD14+ Cells

Dynamic Behavior of Lymphocyte Subgroups Correlates with Clinical Outcomes in Human H7N9 Infection.

Clinical Features And Factors Associated With Outcomes Of Patients Infected With A Novel Influenza A (H7n9) Virus: A Preliminary Study

Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1.

Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019

Evaluation of Plasma Exchange and Continuous Veno-Venous Hemofiltration for the Treatment of Severe Avian Influenza A (H7N9): a Cohort Study.